Just published research involving the University of Cincinnati suggests a form of self-guided behavioral therapy may have big benefits for people with fibromyalgia. Clinical trial results from UC, in ...
AXS-14 (esreboxetine) is a highly selective and potent norepinephrine reuptake inhibitor being developed for the management of fibromyalgia. Esreboxetine is the SS-enantiomer of racemic reboxetine.
How do you know if your pain symptoms are related to fibromyalgia, as opposed to another medical condition? In their quest for answers, individuals with ongoing pain often see one healthcare ...
TNX-102 SL is a sublingual formulation of cyclobenzaprine designed for transmucosal delivery and durable activity in treating fibromyalgia TNX-102 SL demonstrated statistically significant improvement ...
When a patient with fibromyalgia is not responding to standard treatments, adding a noninvasive brain therapy might help them feel better. Repetitive transcranial magnetic stimulation (rTMS) of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results